Mamalis N (2001) Endophthalmitis. J Cataract Refrac Surg 28:729–730. https://doi.org/10.1016/s0886-3350(02)01350-0

Article  Google Scholar 

Lemley C, Han D (2007) Endophthalmitis: a review of current evaluationand management. Retina 27:662–680. https://doi.org/10.1097/IAE.0b013e3180323f96

Article  PubMed  Google Scholar 

Lee CS, Khan M, Patrie J, Bajwa A, Shildkrot YE (2021) Pars plana vitrectomy for endophthalmitis: microbiologic spectrum and clinical outcomes. Ocul Immunol Inflamm 29:871–876. https://doi.org/10.1080/09273948.2019.1698750

Article  CAS  PubMed  Google Scholar 

Endophthalmitis Vitrectomy Study Group (1995) Results of the endophthalmitis vitrectomy study. a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 113:1479–1496

Article  Google Scholar 

Kuhn F, Gini G (2005) Ten years after are findings of the endophthalmitis vitrectomy study still relevant today? Graefes Arch Clin Exp Ophthalmol 243:1197–1199. https://doi.org/10.1007/s00417-005-0082-8

Article  PubMed  Google Scholar 

Do T, Hon DN, Aung T, Hien ND, Cowan CL (2014) Bacterial endogenous endophthalmitis in vietnam: a randomized controlled trial comparing vitrectomy with silicone oil versus vitrectomy alone. Clin Ophthalmol 8:1633–1640. https://doi.org/10.2147/OPTH.S67589

Article  PubMed  PubMed Central  Google Scholar 

Ng JQ, Morlet N, Pearman JW, Constable IJ, McAllister IL, Kennedy CJ et al (2005) Team EPSWA management and outcomes of postoperative endophthalmitis since the endophthalmitis vitrectomy study: the endophthalmitis population study of western australia (EPSWA)’s fifth report. Ophthalmology 112:1199–1206

Article  PubMed  Google Scholar 

Umazume K, Suzuki J, Usui Y, Maruyama K, Wakabayashi Y, Goto H (2019) Absence of posterior vitreous detachment is a risk factor of severe bleb-related endophthalmitis. J Ophthalmol 2019:1585830. https://doi.org/10.1155/2019/1585830

Article  PubMed  PubMed Central  Google Scholar 

Umazume K, Suzuki J, Usui Y, Wakabayashi Y, Goto H (2016) Possible relation between lack of posterior vitreous detachment and severe endogenous endophthalmitis. J Ophthalmol 2016:8561379. https://doi.org/10.1155/2016/8561379

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mezad-Koursh D, Goldstein M, Heilwail G, Zayit-Soudry S, Loewenstein A, Barak A (2010) Clinical characteristics of endophthalmitis after an injection of intravitreal antivascular endothelial growth factor. Retina 30:1051–1057. https://doi.org/10.1097/IAE.0b013e3181cd47ed

Article  PubMed  Google Scholar 

Sachdeva MM, Moshiri A, Leder HA, Scott AW (2016) Endophthalmitis following intravitreal injection of anti-VEGF agents: long-term outcomes and the identification of unusual microorganisms. J Ophthalmic Inflamm Infect 6:2. https://doi.org/10.1186/s12348-015-0069-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gan IM, Van Dissel JT, Beekhuis WH, Swart W, van Meurs JC (2001) Intravitreal vancomycin and gentamicin concentrations in patients with postoperative endophthalmitis. Br J Ophthalmol 85:1289–1293. https://doi.org/10.1136/bjo.85.11.1289

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barry P, Cordovés L, Gardner S (2013) ESCRS guidelines for prevention and treatment of endophthalmitis following cataract surgery: data, dilemmas and conclusions. https://www.escrs.org/media/uljgvpn1/english_2018_updated.pdf. Accessed 16 December 2023

Kuriyan AE, Weiss KD, Flynn HW Jr, Smiddy WE, Berrocal AM, Albini TA et al (2014) Endophthalmitis caused by streptococcal species: clinical settings, microbiology, management, and outcomes. Am J Ophthalmol 157:774–780. https://doi.org/10.1016/j.ajo.2013.12.026

Article  PubMed  PubMed Central  Google Scholar 

Seong HJ, Park YM, Kim J, Son KJ, Chung EJ (2022) Incidence of acute endophthalmitis after intravitreal antivascular endothelial growth factor injection in age-related macular degeneration. Korean J Ophthalmol 36:435–442. https://doi.org/10.3341/kjo.2022.0088

Article  CAS  PubMed  PubMed Central  Google Scholar 

Artunay O, Yuzbasioglu E, Rasier R, Sengül A, Bahcecioglu H (2009) Incidence and management of acute endophthalmitis after intravitreal bevacizumab (Avastin) injection. Eye (Lond) 23:2187–2193. https://doi.org/10.1038/eye.2009.7

Article  CAS  PubMed  Google Scholar 

Lyall DA, Tey A, Foot B, Roxburgh STD, Virdi M, Robertson C et al (2012) Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes. Eye (Lond) 26:1517–1526. https://doi.org/10.1038/eye.2012.199

Article  CAS  PubMed  Google Scholar 

Relhan N, Forster RK, Flynn HW Jr (2018) Endophthalmitis: then and now. Am J Ophthalmol 187:xx–xxvii. https://doi.org/10.1016/j.ajo.2017.11.021

Article  PubMed  Google Scholar 

Avery RL, Bakri SJ, Blumenkranz MS, Brucker AJ Jr, Cunningham ET, D’Amico DJ et al (2014) Intravitreal injection technique and monitoring: updated guidelines of an expert panel. Retina 34:S1–S18. https://doi.org/10.1097/IAE.0000000000000399

Article  CAS  PubMed  Google Scholar 

Baudin F, Benzenine E, Mariet AS, Ghezala IB, Bron AM, Daien V et al (2022) Topical antibiotic prophylaxis and intravitreal injections: impact on the incidence of acute endophthalmitis-a nationwide study in france from 2009 to 2018. Pharmaceutics 14:2133. https://doi.org/10.3390/pharmaceutics14102133

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu K, Mousa R, Loewenstein A, Barak A, Chin EK, Almeidaet DRP (2020) Management and visual outcomes of acute bacterial endophthalmitis following intravitreal injection of contaminated bevacizumab in a single day. Ophthalmic Surg Lasers Imaging Retina 51:346–352. https://doi.org/10.3928/23258160-20200603-05

Article  PubMed  Google Scholar 

Xu K, Chin EK, Bennett SR, Williams DF, Ryan EH, Dev S et al (2018) Endophthalmitis after intravitreal injection of vascular endothelial growth factor inhibitors: management and visual outcomes. Ophthalmology 125:1279–1286. https://doi.org/10.1016/j.ophtha.2018.01.022

Article  PubMed  Google Scholar 

Far PM, Yeung SC, Farimani PL, Qian J, Zhang AQ, Kertes PJ et al (2021) Tap and inject versus pars plana vitrectomy for postprocedural endophthalmitis: a meta-analysis. Retina 41:2009–2016. https://doi.org/10.1097/IAE.0000000000003203

Article  CAS  PubMed  Google Scholar 

Das S, Singh S, Kumar A (2021) Bacterial burden declines but neutrophil infiltration and ocular tissue damage persist in experimental staphylococcus epidermidis endophthalmitis. Front Cell Infect Microbiol 11:780648. https://doi.org/10.3389/fcimb.2021.780648

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dave VP, Joseph J, Jayabhasker P, Pappuru RR, Pathengay A, Das T (2019) Does ophthalmic-grade silicone oil possess antimicrobial properties? J Ophthalmic Inflamm Infect 9:20. https://doi.org/10.1186/s12348-019-0187-6

Article  PubMed  PubMed Central  Google Scholar 

Guo HX, Xie RT, Wang Y, You CY, Liu YY, Meng XD et al (2022) Timely vitrectomy without intraocular lens removal for acute endophthalmitis after cataract surgery. Int J Ophthalmol 15:1011–1014

Article  PubMed  PubMed Central  Google Scholar 

Kang YK, Shin JP, Park HS (2021) Long-term effect of silicone oil tamponade for postoperative and posttraumatic bacterial endophthalmitis. J Ophthalmol 2021:6658281. https://doi.org/10.1155/2021/6658281

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaynak S, Oner FH, Koçak N, Cingil G (2003) Surgical management of postoperative endophthalmitis: comparison of 2 techniques. J Cataract Refract Surg 29:966–969. https://doi.org/10.1016/s0886-3350(02)01892-8

Article  PubMed  Google Scholar 

Nagpal M, Jain P, Nagpal K (2012) Pars plana vitrectomy with or without silicone oil endotamponade in surgical management of endophthalmitis. Asia Pac J Ophthalmol (Phila) 1:216–221. https://doi.o